product, a high-speed planting system. The appeal arose from a District of Delaware case in which Deere sued AGCO-Precision for infringement of two U.S. patents covering a high-speed planting system.

Yesterday, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a per curiam ruling in Huang v. Amazon.com, Inc. affirming the Northern District of California’s dismissal of patent ...

Jan 8 - Data storage provider Western Digital (WDC.O), opens new tab must pay SPEX Technologies more than $237 million in interest on top of $316 million in damages that a jury awarded to SPEX in ...

BioMarin Pharmaceutical (BMRN) announced that the company has initiated a legal action against Ascendis Pharma (ASND) for infringement of European patent EP 3 175 863 B1 at the Unified Patent ...

The lawsuit alleges infringement ... CNP investigational product and its development program, particularly in Germany and other European locations, violates BioMarin's patent rights.

In Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC, the Federal Circuit jumped on the bandwagon ...

There were multiple jury trials, case-dispositive design patent decisions ... aspects of the claimed design and accused products. Regarding infringement of the D’969 patent, the court agreed ...

North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate ...

Chair of Baker Botts’ Federal Circuit Appellate practice group, Michael Hawes assists clients in negotiations and cases on patent and copyright infringement ... medical device and consumer products ...

Once the claims have been construed, they must be compared to the accused product or method 7, which is the second step in determining patent infringement. For this comparison, the individual ...

Primarily, the ongoing patent litigation against Ascendis ... BioMarin’s lawsuit aims to protect its CNP product, Voxzogo, from what it claims is infringement by Ascendis’ TransCon CNP.